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Background: Propofol is known to have a favourable effect on cerebral haemodynamics. The role of nitrous oxide (N2O) in 
neurosurgical anaesthesia is still being debated. The primary aim of this study was to assess the dose-sparing effect of N2O on 
propofol infusion maintenance dosing.
Method: Fifty American Society of Anesthesiology (ASA) grade I and II adults scheduled for elective craniotomies for supratentorial 
tumours were enrolled in the study. The patients received a standard anaesthetic comprising a fentanyl 2  μg/kg bolus prior 
to propofol induction. Anaesthesia was maintained with an infusion of fentanyl (2 μg/kg/hour), atracurium and propofol. The 
patients were randomised into two groups. Group A received 67% N2O. Group B did not receive N2O concomitantly with the 
propofol infusion. Entropy was used to guide the titration of the propofol infusion in both groups.
Results: The propofol maintenance dose requirements were 47% lower in Group A (54.30 ± 11.47 μg/kg/minute) vs. Group B 
(102.30 ± 14.00 μg/kg/minute), (p < 0.001).
Conclusion: The use of supplemental N2O significantly decreased propofol infusion rate requirements, compared with the 
propofol infusion alone, in ASA I and II patients undergoing elective supratentorial tumour excision.
Keywords: anaesthesia depth, entropy, intracranial surgery, nitrous oxide, propofol
Introduction
The maintenance of a strict cerebral physiological balance and 
early recovery for neurological assessment is required for 
neurosurgical anaesthesia. Propofol is a standard induction, as 
well as a maintenance agent, owing to its favourable effects on 
neurophysiology. It causes a dose-dependent decrease in 
intracranial pressure (ICP), while maintaining cerebral perfusion 
at a modest dose, and also decreases the cerebral metabolic rate 
without any disturbance in cerebral vascular reactivity to carbon 
dioxide and autoregulation.1,2 Furthermore, propofol total 
intravenous anaesthesia results in a clinically relevant reduction 
in postoperative nausea and vomiting (PONV). However, the 
potentially higher cost is a concern.3
Nitrous oxide (N2O) is used widely in neuroanaesthetic practice 
as it produces amnesia, analgesia and haemodynamic stability. It 
also enables rapid recovery. It has been shown in clinical trials to 
reduce the dose requirement of other anaesthetic agents.4,5 N2O 
reduces the cost of intravenous anaesthesia.6 We hypothesised 
that the drug-sparing effect of N2O should reflect on the 
maintenance dose requirement of propofol. Still, certain 
controversies surround the role of N2O in neuroanaesthesia 
owing to its unfavourable effects on neurophysiology, and other 
side-effects, such as tension pneumoencephalus, nausea and 
vomiting, a neurological deficit in vitamin B12-deficient patients 
and increased wound infections.7–9 A randomised study was 
conducted to determine the dose requirement of propofol when 
used with and without N2O in patients undergoing an elective 
craniotomy, in which entropy was used to measure depth of 
anaesthesia.10,11 The surgical conditions were also observed, and 
the haemodynamic profile and recovery characteristics 
compared, with and without N2O, in the two groups. The primary 
aim of our study was to evaluate the effect of N2O on propofol 
dose requirement. The secondary aim was to evaluate the safety 
profile of N2O in neuroanaesthesia.
Method
After obtaining approval from the hospital ethics committee and 
receiving the informed consent of the patients, 50 American 
Society of Anesthesiologists (ASA) physical status grade I/II 
patients, of either gender, aged 18–60 years, and scheduled for 
elective craniotomies for supratentorial tumours, were included 
in the study. Patients who were pregnant, drowsy, likely to 
require postoperative mechanical ventilation, who had evidence 
of major cardiopulmonary, hepatic or renal disease, and those 
with a known allergy to the study drugs, were excluded from the 
study.
Patients were kept fasting for six hours and premedicated with 
oral alprazolam 0.5 mg at bedtime, and two hours before surgery.
Monitoring included: 
•  Noninvasive blood pressure.
•  An electrocardiogram.
•  Heart rate.
•  Pulse oximetry.
•  Response entropy (RE).
•  State entropy (SE) [with M-Entropy S/5TM Module® (GE Healthcare)] 
using a sensor attached to the forehead of the patient.
•  Capnography [end-tidal carbon dioxide (EtCO2)].
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•  Invasive arterial blood pressure.
•  Nasopharyngeal temperature.
•  Urine output.
•  A 16-G long line in the cephalic vein to monitor central 
venous pressure (CVP).
•  Expiratory N2O concentration.
•  Oxygen concentration by oxygen analyser.
The patients were randomised into two groups using a random 
digit table. Group A (the N2O group) received a N2O, oxygen and 
propofol infusion, and Group B (the propofol group) received an 
air, oxygen and propofol infusion. A similar type and size of 
supratentorial tumour resection, mostly meningiomas or 
gliomas, were operated on in both the groups. Baseline systolic 
blood pressure (SBP), diastolic blood pressure (DBP), mean blood 
pressure (MBP), heart rate (HR), SE and RE were recorded. The 
patient’s lungs were preoxygenated for three minutes. Fentanyl 
2 µg/kg intravenously was administered, followed by propofol 
2  mg/kg and atracurium 0.5  mg/kg, to facilitate tracheal 
intubation with a flexometallic tube. The propofol infusion was 
started at a rate of 50 µg/kg/minute simultaneously with 
induction, keeping the entropy value  ≤  40 until tracheal 
intubation, and between 40 and 60 intraoperatively. During 
induction and maintenance, the lungs were ventilated using 
67% N2O in oxygen in group A, and 33% oxygen in air in group B, 
maintaining a fraction of inspired oxygen of 33%. Fentanyl (2 µg/
kg/hour) and atracurium (10 µg/kg/minute) infusions were 
started.
The intraoperative entropy score was maintained between 40 
and 60, CVP between 5 cmH2O and 8 cmH2O, EtCO2 between 28 
mmHg and 32  mmHg, and nasopharyngeal temperature 
between 36 °C and 37  °C. Normal saline was used as an 
intravenous fluid to maintain the CVP. Mannitol (1  g/kg) was 
administered over 20 minutes, starting at the time of skin incision 
in all patients. Brain condition was assessed by the operating 
surgeon (who was unaware of the group allocation of the 
patient) after opening the cranial cavity as tense (swollen and 
bulging), reasonable (minimal swelling and acceptable) or ideal 
(no swelling and excellent). Hypotension, a fall in MBP to less 
than 20% of baseline or MBP ≤ 65  mmHg, was treated with 
ephedrine 6  mg intravenously after excluding hypovolaemia. 
Bradycardia (HR ≤ 45/minutes) was treated with glycopyrrolate 
0.2 mg intravenously. Episodes of hypertension or tachycardia (a 
rise of ≥ 20% from baseline) were treated by increasing the 
propofol infusion rate. Atracurium and fentanyl infusions were 
discontinued after dura closure. Propofol and N2O/air were 
stopped after the removal of the head clamps. Residual 
neuromuscular blockade was antagonised with neostigmine 
0.05 mg/kg and glycopyrrolate 0.01 mg/kg, both intravenously. 
The trachea was extubated following the return of adequate 
spontaneous respiration, protective reflexes and an entropy 
score > 70. Heart rate, MBP, SBP and DBP, entropy values (RE and 
SE), EtCO2, and inspiratory and expiratory N2O concentrations 
were recorded at baseline, post induction, post intubation and 
every five minutes thereafter intraoperatively.
Time to eye opening after the cessation of propofol was noted. 
Recovery characteristics were recorded as a modified Aldrete 
score at 10 minutes and 30 minutes postoperatively.
Patients were transferred to the neurointensive care unit (NICU), 
when the modified Aldrete score was ≥ 8. Adverse effects, such 
as nausea and vomiting, or episodes of haemodynamic 
instability, were recorded for six hours in the NICU. Patients were 
questioned 24 hours after surgery about what they remembered 
last, and if they had any memories of the surgery.
The sample size was calculated using data from a previous 
study.12 A sample size of 50 patients was required to achieve a 
33% reduction in effective concentration 50 (EC50) of propofol 
with 67% N2O, with a power of 80% and α of 0.05. Statistical 
analysis was performed using Windows® SPSS® version 12.0. The 
data are presented as continuous variables in terms of mean and 
standard deviation (MBP, DBP, SBP and propofol infusion rate and 
time to eye opening), and as categorical variables in terms of 
percentage (sex and ASA grade). Student’s t-test was used for the 
continuous data after normal distribution of the continuous 
variables validated by the Kolmogorov-Smirnov one-sample 
test, and for catagorical data chi squre test and Fischer’s exact 
test were used. A p-value of ≤ 0.050 was taken to be the level of 
statistical significance.
Results
The two groups were comparable in terms of age, weight, sex 
distribution, ASA grade and duration of anaesthesia (p > 0.050) 
(Table 1).
The mean dose requirement of propofol during maintenance 
was significantly higher (47%) in the propofol group 
(102.30  ±  14.00  μg/kg/minute) compared with the N2O group 
(54.30 ± 11.47 μg/kg/minute) (Table 1).
The intergroup comparison of mean HR at different time intervals 
is shown in Figure 1. The baseline mean HR was comparable 
between the two groups (p 0.967). The mean HR was significantly 
lower in group A (the N2O group) compared to that in group B 
(the propofol group) after five minutes of intubation 
(71.76  ±  13.91 μg/kg/minute vs. 82.56  ±  14.08 μg/kg/minute, 
respectively) (p 0.009). Thereafter, the HR was comparable in 
both the groups (p-value ≥ 0.050).
Table 1: Demographic data, duration of anaesthesia and propofol dose requirement
Note: ASA: American Society of Anesthesiologists, N2O: nitrous oxide.
Demographic data Group A (N2O group) Group B (propofol group) p-value
Age (years) 48.00 ± 13.30 46.20 ± 10.70 0.609
Weight (kg) 63.40 ± 10.60 60.20 ± 7.20 0.268
Sex (male and female) (n, %) 16 (64):9 (3 6) 14 (56):11 (44) 0.564
ASA grade (I and II) (n, %) 12 (48):13 (52) 10 (40):15 (60) 0.569
Duration of anaesthesia (minutes) 161.60 ± 31.10 157.60 ± 31.00 0.651
Propofol dose (μg/kg/minute) 54.30 ± 11.47 102.30 ± 14.00 < 0.001
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The baseline MBP was comparable in the two groups (p 0.573). A 
statistically significant lower MBP was observed in group A at 
post induction, and at five minutes post intubation, compared 
with that in group B. A higher MBP was observed in group B (the 
propofol group) compared with that in group A (the N2O group), 
at several time points, for which an increase in the propofol 
infusion rate was required (Figure 2).
The recovery characteristics are shown in Table 2. The mean time 
to eye opening was significantly longer in group B 
(8.54 ± 8.15 minutes) than in Group A (2.51 ± 1.03 minutes) (p < 
0.001). The Aldrete score was significantly lower in group B than 
in group A at 10 minutes (p 0.001) and at 30 minutes (p 0.039).
There were no intraoperative or postoperative complications, i.e. 
pneumoencephalus, PONV, respiratory depression or the need 
for postoperative ventilatory support, in either group. None of 
the patients in either group reported being aware of 
intraoperative events when questioned 24 hours postoperatively.
Discussion
The results of our study indicate that when N2O was used with 
the propofol infusion for the maintenance of anaesthesia, the 
propofol dose requirement was significantly less compared to 
the propofol infusion alone requirement in patients undergoing 
supratentorial surgery. We found in our study that the 
maintenance dose of propofol was 54.30 ± 11.47 µg/kg/minute, 
and 102.30  ±  14.00 µg/kg/minute, with and without N2O, 
respectively. Thus, the propofol requirement was considerably 
lower when used together with N2O. Davidson et al.
12 reported 
that the addition of 67% N2O reduced the EC50 of propofol by 
33%. Similarly, Dube et al.13 also found that the maintenance 
dose of propofol, with and without N2O, was 71.26 ± 11.78 μg/
kg/minute and 90.82  ±  19.13  μg/kg/minute, respectively. 
Hemelrijck et al.14 reported that the electroencephalography 
(EEG)-titrated propofol requirement was significantly less when 
used with N2O, when compared with the use of propofol alone 
(123  ±  5.27 μg/kg/minute vs.150  ±  2.77  μg/kg/minute, or 
7.4 ± 1.9 mg/kg/hour vs. 9.0 ± 1.0 mg/kg/hour). Singh et al.15 also 
reported that there was an increased consumption of opioids 
and muscle relaxants in the N2O-free group of patients 
undergoing supratentorial tumour surgery. This emphasises the 
analgesic potency of N2O. Ng and Hwang
5 found that the co-
administration of N2O during the induction of anaesthesia 
reduced the induction dose requirement of propofol.
A propofol requirement of 100-200 µg/kg/minute, together with 
N2O and an opioid analgesic in orthopaedic surgery,
16 Caesarean 
section and other surgery, has been demonstrated in previous 
Figure 1: Heart rate trend in the study.
Star denotes significance; p < 0.05
Figure 2: Mean blood pressure trend in the study.
Note: MBP: mean blood pressure. Star denotes significance; p < 0.05
Table 2: Recovery characteristics of the study participants*,**
Note: N2O: nitrous oxide.
*: Values are expressed as mean ± standard deviation.
**: A difference was not found in the intraoperative condition of the brain in both groups (p 0.600) (Table 3).
Time (minutes) Group A (N2O group) Group B (propofol group) p-value
Time to eye opening (minutes) 2.51 ± 1.03 8.54 ± 8.15 < 0.001
Aldrete score at 10 minutes 9.24 ± 0.77 7.88 ± 1.61 0.001
Aldrete score at 30 minutes 10.00 ± 0.00 9.84 ± 0.37 0.039
Table 3: Intraoperative brain status of the study participants
Note: N20: nitrous oxide.
*:Values are expressed as number (per cent).
Brain status Group A (N20 group)
* Group B (propofol group) p-value
Tense (swollen and bulging) 1 (4) 0 (0)
0.600Reasonable (minimal swelling and acceptable) 23 (92) 24 (96)
Ideal (no swelling and excellent) 1 (4) 1 (4)
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The Aldrete score at 10  minutes of cessation of the propofol 
infusion revealed that recovery was significantly faster in the N2O 
group compared to that in the propofol group. This is probably 
because of the significantly higher dose of propofol required by 
patients in the propofol group. The Aldrete score at 30 minutes 
was statistically significantly different between the two groups, 
although the difference was not clinically significant.
The surgical conditions assessed by the surgeon were 
comparable in the two groups. Hemelrijck et al.14 also reported 
that the surgical conditions (brain relaxation) were similar in the 
two groups.
PONV is unacceptable following neurosurgical procedures. N2O 
has been implicated in causing PONV. 27,28 However, none of the 
patients in our study experienced nausea or vomiting. This could 
be owing to the antiemetic action of propofol. Although N2O has 
been implicated in complications, such as raised ICP and 
pneumoencephalus,29,30 these were not observed in our study. 
Singh et al.15 also found that using N2O in patients undergoing 
supratentorial craniotomies did not prolong the duration of 
intensive care unit or hospital stay.
The unfavourable effects of N2O on neurophysiology, such as an 
increase in the cerebral metabolic rate, cerebral blood flow and 
ICP, have caused its role in neuroanaesthesia to be debated.7,9 To 
an extent, these effects of N2O are masked by the concomitant 
use of propofol.31 The impact of these unfavourable effects of 
N2O were not found in our study on awake (albeit with a small 
rise in ICP) patients. Since patients with significantly raised ICP, or 
who were drowsy, were not included in our study, the results 
cannot be extrapolated to such patients.
Conclusion
We conclude that the use of supplemental N2O significantly 
decreased the propofol infusion rate requirement, compared 
with a propofol infusion alone, in ASA I and II awake patients 
undergoing supratentorial craniotomies.
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